In the last completed session, Zydus Lifesciences Ltd. closed -0.19% with futures open interest moving +2.3%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.68, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,070 sits 0.6% below the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Zydus Lifesciences Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Zydus Lifesciences Ltd. suggests further downside pressure is likely.
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 27%
Δ 0.80
θ -0.6
ν 1
|
1020 |
IV 26%
Δ -0.19
θ -0.3
ν 1
|
|
IV 25%
Δ 0.77
θ -0.6
ν 1
|
1030 |
IV 26%
Δ -0.23
θ -0.4
ν 1
|
|
IV 28%
Δ 0.71
θ -0.6
ν 1
|
1040 |
IV 25%
Δ -0.27
θ -0.4
ν 1
|
|
IV 27%
Δ 0.67
θ -0.6
ν 1
|
1050 S |
IV 25%
Δ -0.32
θ -0.4
ν 1
|
|
IV 26%
Δ 0.63
θ -0.7
ν 1
|
1060 |
IV 25%
Δ -0.37
θ -0.4
ν 1
|
|
IV 26%
Δ 0.58
θ -0.7
ν 1
|
1070 MP |
IV 25%
Δ -0.42
θ -0.4
ν 1
|
|
IV 26%
Δ 0.52
θ -0.7
ν 1
|
1080 |
IV 24%
Δ -0.48
θ -0.4
ν 1
|
|
IV 26%
Δ 0.47
θ -0.7
ν 1
|
1090 |
IV 25%
Δ -0.53
θ -0.4
ν 1
|
|
IV 26%
Δ 0.42
θ -0.6
ν 1
|
1100 R |
IV 25%
Δ -0.58
θ -0.4
ν 1
|
|
IV 26%
Δ 0.37
θ -0.6
ν 1
|
1110 |
IV 17%
Δ -0.71
θ -0.2
ν 1
|
|
IV 27%
Δ 0.33
θ -0.6
ν 1
|
1120 |
IV 23%
Δ -0.70
θ -0.3
ν 1
|
|
IV 27%
Δ 0.29
θ -0.6
ν 1
|
1130 |
IV 32%
Δ -0.68
θ -0.5
ν 1
|
|
IV 27%
Δ 0.25
θ -0.5
ν 1
|
1140 |
IV 186%
Δ -0.44
θ -3.8
ν 1
|